• Explore /
  • Poster
  • / Outcomes by BCL2 and MYC expression and rearrangements in untreated diffuse large B-cell lymphoma (DLBCL) from the POLARIX trial.

Outcomes by BCL2 and MYC expression and rearrangements in untreated diffuse large B-cell lymphoma (DLBCL) from the POLARIX trial.

Abstract Video & Slides Poster

Authors

null

Franck Morschhauser

Lille University Hospital Center, Lille Cedex, France

Franck Morschhauser , Yanwen Jiang , Fabrice Jardin , Alex Francisco Herrera , Laurie Helen Sehn , Charles Herbaux , Christopher Flowers , Tycel Jovelle Phillips , Armando López Guillermo , Catherine S. Magid Diefenbach , Gareth Gregory , Austin Injae Kim , Anna Maria Barbui , Sandhya Balasubramanian , Will Harris , Jamie Hirata , Joseph N. Paulson , Calvin Lee , Georg Lenz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Non-Hodgkin Lymphoma

Clinical Trial Registration Number

NCT03274492

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 7517)

DOI

10.1200/JCO.2022.40.16_suppl.7517

Abstract #

7517

Poster Bd #

171

Abstract Disclosures

Similar Posters

First Author: Umberto Vitolo

First Author: Chrissie Rozzi

First Author: Mohamad Barakat

First Author: Amir Issa